Komori
Nissan Chemical (4021) · RiskMaterialised

Concentration in Products Driving Financial Performance and Delays in Generating Actual Demand for New Products

First written in FY2018. 2 of 3 entries say "Materialised", first in FY2022. Latest entry: FY2024.

3entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2018MaterialisedFY2022 – FY20242018: 120182019: 020192020: 020202021: 020212022: 120222023: 020232024: 12024
Same theme, other companies
Sales shortfall due to delayed ramp-up of new series and experimental worksA theme 2 companies write about · 2 as a headwind · 0 as a tailwind

Nissan Chemical moved to the "Worse" side of this theme in 2022.

0 other companies' latest entry also says "Materialised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2024MaterialisedAnnual report

    「We take seriously that this is due not only to significant changes in the external environment, including demand, raw materials and foreign exchange, and the effects of natural disasters, but also to the concentration of businesses driving performance and delays in creating new products that should serve as growth engines contributing to higher margins.」

    The document states that concentration in businesses driving performance and delays in creating new products were reflected in the results as factors behind lower revenue, lower profit and the end of record-high performance in the fiscal year ended March 2024.
  2. FY2022MaterialisedAnnual report

    「Although recent performance is strong, the company must acknowledge that it has yet to create the new businesses needed to realize the desired state under Progress2030.」

    The company explicitly states that it has not achieved the creation of new businesses, addressing the previously identified risks of concentration in products driving performance and delays in creating new businesses.
  3. FY2018First statedAnnual report

    「Although recent performance is strong, the company recognizes that, compared with the original plan, performance is concentrated in the products driving results and the commercialization of new products has been delayed.」

    The company identifies the concentration of performance in certain products and delays in commercializing new products as issues to consider in formulating the Stage II growth strategy.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Nissan Chemical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Concentration in Products Driving Financial Performance and Delays in Generating Actual Demand for New Products | Nissan Chemical Corporation (4021) | Komori